BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33417954
Number of visits today
3321
Number of downloads
16607577
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Yang J, Tseng J, Yu G, Luo Y, Huang CF, Hong Y, Chuang T. Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases. Pharmaceutics 2022;14:423. [DOI: 10.3390/pharmaceutics14020423] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Verma SK, Mahajan P, Singh NK, Gupta A, Aggarwal R, Rappuoli R, Johri AK. New-age vaccine adjuvants, their development, and future perspective. Front Immunol 2023;14:1043109. [PMID: 36911719 DOI: 10.3389/fimmu.2023.1043109] [Reference Citation Analysis]
2 Bhoge PR, Mardhekar S, Toraskar S, Subramani B, Kikkeri R. Pairing Nanoparticles Geometry with TLR Agonists to Modulate Immune Responses for Vaccine Development. ACS Appl Bio Mater 2022;5:5675-81. [PMID: 36375049 DOI: 10.1021/acsabm.2c00716] [Reference Citation Analysis]
3 Mishra R, Sharma S, Arora N. TLR-5 ligand conjugated with Per a 10 and T cell peptides potentiates Treg/Th1 response through PI3K/mTOR axis. International Immunopharmacology 2022;113:109389. [DOI: 10.1016/j.intimp.2022.109389] [Reference Citation Analysis]
4 Archana Gopalakrishnan, Katharina Richard, Rezwanul Wahid, Regina Harley, Marcelo B. Sztein, Lynn D. Hawkins, Stefanie N. Vogel. E6020, a TLR4 Agonist Adjuvant, Enhances both Antibody Titers and Isotype Switching in Response to Immunization with Hapten-Protein Antigens and Is Diminished in Mice with TLR4-signaling Insufficiency. J Immunol 2022;209. [PMID: 36426935 DOI: 10.4049/jimmunol.2200495] [Reference Citation Analysis]
5 Aiello A, Ligotti ME, Garnica M, Accardi G, Calabrò A, Pojero F, Arasanz H, Bocanegra A, Blanco E, Chocarro L, Echaide M, Fernandez-rubio L, Ramos P, Piñeiro-hermida S, Kochan G, Zareian N, Farzaneh F, Escors D, Caruso C, Candore G. How Can We Improve Vaccination Response in Old People? Part I: Targeting Immunosenescence of Innate Immunity Cells. IJMS 2022;23:9880. [DOI: 10.3390/ijms23179880] [Reference Citation Analysis]
6 Atapour A, Vosough P, Jafari S, Sarab GA. A multi-epitope vaccine designed against blood-stage of malaria: an immunoinformatic and structural approach. Sci Rep 2022;12:11683. [PMID: 35804032 DOI: 10.1038/s41598-022-15956-3] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345